| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UKNOWN |
| UNII: | 8A9RZ3HN8W |
Structure
| InChI Key | UGJWRPJDTDGERK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C9H16Br2N5O4P |
| Molecular Weight | 449.04 |
| AlogP | 1.92 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 111.32 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 21.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
|
- | 301-4838 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 2 | D008545 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Esophageal Neoplasms | 1 | D004938 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL260046 |
| DrugBank | DB06091 |
| EPA CompTox | DTXSID60238721 |
| FDA SRS | 8A9RZ3HN8W |
| Guide to Pharmacology | 8695 |
| SureChEMBL | SCHEMBL2357174 |
| ZINC | ZINC000029053729 |
CONTENTS